EMI

Create an alert
to follow the executive moves at EMI.

Most searched biographies at EMI

• Yutaka Niihara, Chairman of the Board of Directors, Chief Executiv...
• Wei Peu, Director
• Masaharu Osato, Director

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about EMI

Michigan Revises Prior Authorization Criteria for Endari® - Emmaus Medical, Inc.
Emmaus Life Sciences Launches Endari® Support Program - Emmaus Medical, Inc.
Endari® Granted Orphan Drug Status in Switzerland - Emmaus Medical, Inc.
Emmaus Life Sciences Submits Temporary License Application in Bahrain for Endari® - Emmaus Medical, Inc.
FDA Approves Updated Label for Endari® - Emmaus Medical, Inc.

EMI on Wikipedia, Google News & Yahoo Finance

EMI on LinkedIn, Twitter & YouTube

EMI has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).

Contact by email its executives including Yutaka Niihara

Call EMI at +1 310....

View the org chart

Register to receive your alert

Report an error